Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Cancer Management and Research|July 2, 2020
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung CancerSatoshi Igawa, Taihei Ono, Masashi Kasajima, et al.
Cancer Biomarkers : Section a of Disease Markers|April 26, 2021
Implementation of clinical sequencing for molecular profiling in patients with advanced cancerTomoya Fukui, Kazuko Sakai, Jiichiro Sasaki, et al.
Investigational New Drugs|May 17, 2020
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancerSatoshi Igawa, Taihei Ono, Masashi Kasajima, et al.
Investigational New Drugs|November 22, 2021
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational studySatoshi Igawa, Tomoya Fukui, Masashi Kasajima, et al.
Investigational New Drugs|May 4, 2017
Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancerSatoshi Igawa, Sakiko Otani, Yoshiro Nakahara, et al.
Journal of the American Chemical Society|October 16, 2003
Homoleptic cyclometalated iridium complexes with highly efficient red phosphorescence and application to organic light-emitting diodeAkira Tsuboyama, Hironobu Iwawaki, Manabu Furugori, et al.
International Journal of Clinical Oncology|May 14, 2010
Amrubicin for treating elderly and poor-risk patients with small-cell lung cancerSatoshi Igawa, Shinichiro Ryuge, Tomoya Fukui, et al.
Lung Cancer (Amsterdam, Netherlands)|May 5, 2009
Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinomaSatoshi Igawa, Haruyasu Murakami, Toshiaki Takahashi, et al.
Cancer|July 10, 2024
Cardiovascular safety of pimitespib in patients with advanced solid tumors: An open-label, nonrandomized, phase 1 studyKatsuhiko Naoki, Satoshi Igawa, Haruki Uojima, et al.
International Journal of Clinical Oncology|December 8, 2009
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancerHideyuki Harada, Nobuyuki Yamamoto, Toshiaki Takahashi, et al.
Pageof 11